Results 141 to 150 of about 50,409 (184)

SCAMP3-Driven Regulation of ERK1/2 and Autophagy Phosphoproteomics Signatures in Triple-Negative Breast Cancer. [PDF]

Int J Mol Sci
Morales-Cabán BM, Cantres-Rosario YM, Tosado-Rodríguez EL, Roche-Lima A, Meléndez LM, Boukli NM, Suarez-Arroyo IJ.   +6 more
europepmc   +1 more source

EC359 Enhances Trametinib Efficacy in <i>Ras</i>/<i>Raf</i>-Driven Ovarian Cancer by Suppressing LIFR Signaling. [PDF]

Biomolecules
Arnold WC, Panneerdoss DM, Subramani B, Mahajan M, Ebrahimi B, Ramirez P, Santhamma B, Viswanadhapalli S, Kost ER, Chen Y, Lai Z, Nair HB, Vadlamudi RK, Lyons YA.   +13 more
europepmc   +1 more source

Clinical Significance and Potential Molecular Mechanisms of Angiotensin-Converting Enzyme 2 in Colorectal Cancer. [PDF]

World J Oncol
Zeng DT, Yang L, Wen JY, Wu KJ, Chen GQ, Li ZY, Ling JW, Huang BB, Xie YY, Dong YY, Fang YY, Wei DM, Chen G, Shi L, Huang WJ.   +14 more
europepmc   +1 more source

A Complete Response to Immunotherapy in a Patient with Locally Advanced Squamous Cell Lung Cancer Harboring a Novel <i>TMEM178B::BRAF</i> Fusion: A Case Report. [PDF]

Diagnostics (Basel)
Redondo-González JC, San Miguel I, Rodríguez-González M, Montero JC, Sayagués JM, Abad Hernández M, Fonseca Sánchez E, Del Barco-Morillo E, Olivares-Hernández A.   +8 more
europepmc   +1 more source

RAF1 as a standalone therapeutic target in KRAS-driven lung adenocarcinoma: No added efficacy from co-targeting ARAF, EGFR, or DDR1. [PDF]

PLoS One
de-la-Puente-Ovejero L, Fernández-Rodríguez A, Francoz S, Aizpurua G, Lomba-Riego L, Drosten M, Guerra C, Musteanu M, Barbacid M, García-Alonso S.   +9 more
europepmc   +1 more source

大腸粘膜上皮細胞の恒常性と炎症における、Spred2の新たな役割 [PDF]

, 2017
Takahashi, Sakuma
core  

Protein kinase-related tumors in the pediatric population : Updated review on an emerging group with emphasis on the more rarely involved kinases. [PDF]

Pathologie (Heidelb)
Flucke U, Versleijen-Jonkers YMH, Mentzel T, Mueller AM, Hiemcke-Jiwa LS, Alaggio R.   +5 more
europepmc   +1 more source

Targeting BRAF in cancers - from molecular diagnostics to personalized therapy. [PDF]

BioTechnologia (Pozn)
Pyc Z, Rygiel R, Michalowska D, Ekiert M, Laczmanska I.   +4 more
europepmc   +1 more source

NRas Nanoclusters Mediate Crosstalk Between BRAF/ERK and PI3K/AKT Signaling in Melanoma Cells. [PDF]

Int J Mol Sci
Yakovian O, Sajman J, Sherman E.
europepmc   +1 more source

Targeting the protein-protein interaction between the CDC37 cochaperone and client kinases by an allosteric RAF dimer breaker. [PDF]

J Biol Chem
Yu A, Banerjee S, Malasani S, Towolawi B, Liu Z, Wang Z.   +5 more
europepmc   +1 more source